The three-dose vaccine, named as 'ThRabis’, is a recombinant nano-particle based G protein vaccine which is prepared using Virus-like Particle technology, the company said in a release, adding that the three-dose schedule is spread over only one week.
The deceased employees were a part of the company's production and packaging departments, a spokesperson said.
A senior government official said late on Thursday that five employees had tested positive for COVID-19 six days back, while 21 others tested positive this week.
The pharma firm already has 200 brands, with three or four being in the top five in India, says Rajiv Modi, Chairman & MD, Cadila Pharmaceuticals.